Clinical Trial Update: High-Dose Ambroxol in GBA1-Related Parkinson [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial investigating high-dose ambroxol for Parkinson's disease related to GBA1 mutations; status TBD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ambroxol (Ambroxol)

Snippet

Sponsor: Agyany Pharma LTD | Conditions: Parkinson Disease, GBA Gene Mutation | Phase 1, Phase 2 | Status: UNKNOWN